ErgoSuture's suturing solutions are designed by surgeons for surgeons, and they represent a promising investment opportunity for those looking to get involved in the future of suturing technology.

ErgoSuture's focus on safety, efficiency, and innovation has created products that shorten suturing time, enhance needle control, and reduce tissue damage.

This will lead to significant efficiency gains in the operating room and hospital surgical wards, potentially generating a strong return on investment for investors.


Our innovative RBS platform revolutionizes surgical suturing, making it more time-efficient AND safer, offering unparalleled OR time and costs reduction.

This technology works across the entire surgical spectrum, and its adaptability to both laparoscopic and robotic surgery confers a broad market reach.

Its ability to significantly reduce suturing time translates into cost savings and increased operational efficiency in several OR settings, hospitals, and ambulatory surgery centers.


The Drive'N Roll system is a game-changer in suturing. It's designed to streamline the suturing process, reducing the time and stress associated with this critical surgical task.

It is also designed to fit into most surgeons’ hands and minimize wrist movement, extending their lifespan.

This efficiency gain will lead to cost savings in the operating room, making it an attractive option for healthcare providers and a promising investment opportunity.


When mounted to a surgical robot (RAS), our end-effectors transform into multi-functional tools.

This versatility reduces tool replacement downtime and streamlines the surgical procedure, increasing operational efficiency.

The potential for enhanced patient safety and reduced liability risks adds to its investment appeal.


The X-Needle is a proprietary solution simplifying the suturing process, reducing challenges, and minimizing tissue trauma.

Its design and functionality will increase adoption rates, driving growth and profitability in the surgical & wound closure device market.


Our goal is to introduce the first-ever suture-based Transcatheter solution. Applied to Mitral Valve Repair (TMVR), it will be a viable solution for a significant global patient population suffering from Mitral and Tricuspid Valve Regurgitation (MVR & TVR).

This innovative solution represents a unique market opportunity with no comparable solutions and the potential for very high returns on investment.

Investing in ErgoSuture offers a once-in-a-lifetime opportunity to raise global standards of care for multiple surgical applications. Our devices disrupt but simplify surgical suturing, reducing the risk of mistakes and mishaps while significantly reducing overall suturing time and costs.

With broad applicability across all surgical settings, including Robot-Assisted Surgeries and Transcatheter Applications, ErgoSuture presents a compelling investment proposition with significant global market potential and an enormous upside to existing projections.


  • Dr. A. Lopez
    "Easy to use device for both right and left- handed surgeons in hard to reach places. Improves operational maneuverability for Urologists. Anticipated fast learning curve to gain proficiency in handling device"
  • Dr. J Salgado
    "More versatile device for pelvic procedures. Suturing of the Urethra & Endometriosis, etc. It could also be adopted to laparoscopic and robot-assisted devices".


Surgeons performing general, bariatric, thoracoscopic, and cardio-vascular surgery, urological, gynecological or veterinary procedures will find our RBS solutions to be a must-have going forward and the future gold standard in laparoscopic & robotic suturing.
ErgoSuture - making an impact in the operating room and beyond by scaling innovation and facilitating improved surgical outcomes.


Our disruptive Roller Based Suturing Platform offers investors a great opportunity to get in on the ground floor of a future global standard of care application.
We make Surgical Suturing easier, safer and faster regardless of Surgeon’s original proficiency level by cutting down steps in the suturing process, thus reducing the risk for mistakes and mishaps.
All this while safely reducing overall suturing time at a significant clip.
Our devices are applicable to all surgical settings, including Robot-Assisted Surgeries.


By making surgical suturing easier, safer, and faster, we provide significant efficiency gains and sound hospital economics. The device has an approximate 30 minutes learning curve as it is fundamentally similar to a traditional needle driver.
The main difference is that the flat tips have been replaced by rollers enabling surgeons to leverage their training, experience, and muscle memory, and improving their needle handling, resulting in easier, better, and faster suturing.
Our projected cost per procedure for the device(s) is also very competitive. REUSABLE.


Animals are an important part of everyday human lives, whether as livestock or as housemate pets.
Animals deserve the best medical and surgical care too. Ergosuture’s roller-based suturing (RBS) platform applies to animal surgical care to be used by veterinarians.
Contact us to explore how our RBS technology can be an important part of your daily surgical veterinary practice in the very near future.


We are always exploring and evaluating new partnerships with Distributors around the world
Roller Based Suturing
As a global player with local expertise and service teams, we are represented in more and more countries
– and we continue to grow.


Please contact us at:
if you are in North America and interested in a DEMO of the device(s).

If you are located in the EU/UK, Middle East or Africa, please contact

Alternatively, please call us at: 1-866-473-9204 or 339-234-6289

1Are any RBS devices commercially available already and how can I acquire one?

Answer: Ergosuture intends to launch their first RBS Device, the Drive'N Roll 5mm Laparoscopic Needle Driver, in the first part of 2025.

We'd love to DEMO our platform for you at your earliest convenience so please go to the "Request A DEMO/TRIAL" Section of the website and sign up.

2Will the RBS Technology help an average Surgeon become more proficient?

Answer: Yes, by transferring the skillset needed to consistently and safely drive a surgical needle through tissue in an elliptical arc from the device to the Surgeon, the RBS technology improves on a Surgeons accuracy and suturing speed.

By cutting down on the number of steps required in the suturing process, RBS simultaneously reduces the risk for mistakes and tissue-tearing as well.

Also as a teaching tool for residents and future specialized surgeons.

ErgoSuture is a medical device company with innovative suturing solutions for closing various patient tissue layers, using rollers instead of flat tips to drive surgical needles. ErgoSuture was founded by ErgoSurgical Group, a medical device research boutique, which partners with subject matter experts to develop surgical solutions that help improve suturing safety, speed and versatility.

ErgoSuture owns all patents and products related to rotational driver's technology and has full freedom to operate worldwide. Our product lines empower surgeons and other trained caregivers to close up patient's deep-tissue incisions and wounds easier, safer and faster and at a lower cost per procedure.

ErgoSuture is rapidly growing into a global organization with EMEA HQ based out of the Netherlands, R&D based in San Diego, CA and Medical Affairs operating out of France. Through our Roller Based Suturing (RBS) platform, we are improving suturing proficiency across all surgical settings, from Open to Minimally Invasive Surgery (MIS), including both Laparoscopic and Robot-Assisted Surgeries (RAS).

Our Mission: Driving surgical innovations through the design and development of advanced suturing systems for closing patient skin and deep-tissue openings is OUR MISSION.

Our Vision: Is to offer comprehensive suturing solutions that become universal standards of care and broadens surgical ACCESS worldwide.


Claude Nogard

CEO & Co-Founder

Scott Seligman

CTO - Chief
Technology Officer

Tarek Hamza

Chief Medical Officer

Marc Schoutens

General Manager